» Articles » PMID: 22967897

MiR-136 Promotes Apoptosis of Glioma Cells by Targeting AEG-1 and Bcl-2

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2012 Sep 13
PMID 22967897
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs have the capacity to coordinately repress multiple target genes and interfere with biological functions of the cell, such as proliferation and apoptosis. Here we report that miR-136 is downregulated in human glioma, and that the miRNA promotes apoptosis of glioma cells induced by chemotherapy. Two anti-apoptotic genes, AEG-1 and Bcl-2, are identified as targets of miR-136, and restoration of AEG-1 or Bcl-2 expression suppresses miR-136-enhanced apoptosis. Therefore, miR-136 might play a tumor-suppressive role in human glioma and thereby might represent a potential therapeutic strategy.

Citing Articles

Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study.

Yang L, Niu Z, Ma Z, Wu X, Vong C, Li G Cancer Cell Int. 2024; 24(1):323.

PMID: 39334350 PMC: 11437892. DOI: 10.1186/s12935-024-03507-x.


Non-coding RNAs as therapeutic targets in cancer and its clinical application.

Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y J Pharm Anal. 2024; 14(7):100947.

PMID: 39149142 PMC: 11325817. DOI: 10.1016/j.jpha.2024.02.001.


Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS).

Heidarzadehpilehrood R, Pirhoushiaran M Noncoding RNA Res. 2024; 9(2):624-640.

PMID: 38571815 PMC: 10988127. DOI: 10.1016/j.ncrna.2024.01.002.


Editorial: The role of transcription factors, stem cell markers and epigenetics contributing to chemoresistance in brain cancers.

Castresana J, Shahi M, Sharma A Front Oncol. 2023; 13:1263469.

PMID: 37727217 PMC: 10505812. DOI: 10.3389/fonc.2023.1263469.


Involvement of extracellular vesicles in the progression, diagnosis, treatment, and prevention of whole-body ionizing radiation-induced immune dysfunction.

Seim R, Herring L, Mordant A, Willis M, Wallet S, Coleman Jr L Front Immunol. 2023; 14:1188830.

PMID: 37404812 PMC: 10316130. DOI: 10.3389/fimmu.2023.1188830.